+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

HIV

Human Immunodeficiency Virus (HIV) is a retrovirus that primarily targets and destroys CD4+ T-cells, crucial components of the human immune system. This progressive destruction leads to a compromised immune response, rendering the body vulnerable to opportunistic infections and certain cancers. If left untreated, HIV infection can advance to Acquired Immunodeficiency Syndrome (AIDS), the most severe stage of the disease. While there is currently no cure, effective antiretroviral therapy (ART) can manage the virus, prevent progression, and allow individuals to lead long, healthy lives.
Catalog No Product Description CAS No. Purity Structural Formula
BP1323
Solasonine
Solasonine displays leishmanicidal activity against promastigote forms of L. amazonensis. Solasonine is a steroid, an azaspiro compound and an oxaspiro compound.
19121-58-5 98% Solasonine
BP0341
Chelerythrine chloride
Chelerythrine is a well-known protein kinase C inhibitor, can inhibit telomerase activity, it also can block the human P2X 7 receptor. Chelerythrine has antimanic, potential antiproliferative and antitumor effects, it has significant cytotoxic effect, independent of p53 and androgen status, on human prostate cancer cell lines. Chelerythrine chloride is a benzophenanthridine alkaloid.
3895-92-9 98% Chelerythrine chloride
BP0099
7-Ethyl-10-Hydroxycamptothecin
7-Ethyl-10-Hydroxycamptothecin is a member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. It has a role as an antineoplastic agent, a drug metabolite, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and an apoptosis inducer. 7-Ethyl-10-hydroxycamptothecin shows cytotoxicity against breast cancer, it efficiently target-bind to the colon and lungs of mice.
86639-52-3 98% 7-Ethyl-10-Hydroxycamptothecin
BP3089
Bruceine A
Bruceine A has antibabesial activity, it can inhibit the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration and kill the parasites within 24 hr at a concentration of 25 nM; it show strong antitrypanosomal activities with IC(50) values in the range of 2.9-17.8nM. Bruceine A has anthelmintic activity, it exhibits significant activity against Dactylogyrus intermedius with EC(50) values of 0.49 mg/L. Bruceine A exhibits NF-κB p65 inhibition, and cytotoxic potential against HT-29, HeLa, and HL-60 cells .
25514-31-2 98% Bruceine A
BP0095
6-Shogaol
6-Shogaol has anti-cancer, neuroprotective, anti-inflammatory effects, it can inhibit the growth of human pancreatic tumors and sensitize them to gemcitabine by suppressing of TLR4/NF-κB-mediated inflammatory pathways linked to tumorigenesis. 6-Shogaol induces apoptosis in human hepatocellular carcinoma cells in relation to caspase activation and endoplasmic reticulum (ER) stress signaling, affects the ER stress signaling by regulating unfolded protein response (UPR) sensor PERK and its downstream target eIF2α.
555-66-8 98% 6-Shogaol
BP5527 96158-11-1 98% Hemsloside Ma3
BP2322 103476-95-5 98% Isohanalpinone
BP0939
Methyl protodioscin
Methyl protodioscin has anti-thrombosis, antiosteoporotic, anti-myocardial infarction, and cytotoxic activities. Methyl protodioscin shows strong cytotoxicity against most cell lines from solid tumors with GI50 ≤10.0 microM, but moderate cytotoxicity is shown against leukemia cell lines with GI50 10-30 microM. It potentially increase HDL cholesterol while reducing LDL cholesterol and triglycerides, it also can treat diverse inflammatory pulmonary diseases.
54522-52-0 98% Methyl protodioscin
BP2237 1260151-65-2 98% 6α-(2-methybutyryloxy)-Britannilactone
BP3207
Isocurcumenol
Isocurcumenol inhibits 5α-reductase which converts testosterone to dihydrotestosterone (DHT).
24063-71-6 98% Isocurcumenol
BP2256 165393-48-6 98% Bis[6-(5,6-dihydrochelerythrinyl)]amine
BP3282
O-glucopyranosylepiederagenin, 28-
Hederagenin 28-O-beta-D-glucopyranoside is a triterpenoid saponin that is the carboxylic ester obtained by the formal condensation of the carboxy group of hederagenin with beta-D-glucopyranose. It has been isolated from Juglans sinensis. It has a role as an anti-inflammatory agent and a plant metabolite. It is a beta-D-glucoside, a pentacyclic triterpenoid, a carboxylic ester, a triterpenoid saponin and a monosaccharide derivative. It is functionally related to a hederagenin.
53931-25-2 98% O-glucopyranosylepiederagenin, 28-
BP1229
Rubitecan
Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. It has a role as an antineoplastic agent, a prodrug and an EC 5.99.1.2 (DNA topoisomerase) inhibitor. It is a delta-lactone, a tertiary alcohol, a C-nitro compound, a pyranoindolizinoquinoline and a semisynthetic derivative. Rubitecan is a novel oral inhibitor of topoisomerase I in the camptothecin class. It shows antitumour activity in patients with refractory pancreatic cancer who have failed prior treatments.
91421-42-0 98% Rubitecan
BP0367
Cinobufotalin
Cinobufotalin is a main cardiac toxin in toad, it is a novel anti-HCC agent, it induces growth inhibition and apoptosis in cultured HCC cells through ceramide production. Cinobufotalin is also an effective reversal agent for the multidrug resistance of tumors, it can reverse the adriamycin-resistance in Raji/ADR cells and the expression of P-gp and MRP-1 proteins. Cinobufotalin can promote the dendritic cells(DCs) derived from peripheral blood of patients with chronic hepatitis B to mature and effectively enhance its(the DCs') capabilities, therefore the treatment of cinobufotalin may potentiate the antiviral immunity of the patients with chronic hepatitis B(CHB).
1108-68-5 98% Cinobufotalin
BP1408
Trigonelline Hydrochloride
Trigonelline chloride, an alkaloid with potential antidiabetic activity, is present in considerable amounts in coffee. Trigonelline hydrochloride reduces diabetic auditory neuropathy by affecting β cell regeneration.
6138-41-6 98% Trigonelline Hydrochloride
SBP03388
4-Methylumbelliferone
4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM, which has antitumoral and antimetastatic effects. 4-Methylumbelliferone may inhibit the phosphorylation of HAS2 by PKC through the stimulation of O-GlcNAcylation; it also similarly ameliorates hypertriglyceridemia and hyperglycemia partly by modulating hepatic lipid metabolism and the antioxidant defense system along with increasing adiponectin levels. 4-methylumbelliferone is a hydroxycoumarin that is umbelliferone substituted by a methyl group at position 4. It has a role as a hyaluronic acid synthesis inhibitor and an antineoplastic agent. It is functionally related to an umbelliferone.
90-33-5 98% 4-Methylumbelliferone
SBP01651 35241-80-6 9-Methoxy-α-lapachone
BP2124 117803-96-0 98% Taccalonolide C
BP1702
Morellic acid
Morellic acid has anti-cancer activity, it strongly inhibited the migration of HUVEC at a low concentration of 0.5 μM in HUVEC cell migration assay in vitro. Morellic acid also has antiangiogenic activity.
5304-71-2 98% Morellic acid
BP4788
Maltotriose
Maltotriose is a maltotriose trisaccharide in which the glucose residue at the reducing end is in the aldehydo open-chain form.
1109-28-0 98% Maltotriose